Synergy Chc Corp is a public company that specializes in developing innovative healthcare solutions, primarily focusing on creating and distributing pharmaceutical products and dietary supplements. The company emphasizes research and development to enhance the effectiveness and accessibility of its offerings, catering to various health needs. Through strategic partnerships and a commitment to quality, Synergy Chc Corp aims to improve patient outcomes and contribute positively to the wellness industry. Its portfolio potentially spans over a range of therapeutic areas, positioning the company as a key player in the healthcare market. Read More
The CHIPS and Science Act, a landmark $280 billion initiative, is designed to bolster domestic semiconductor manufacturing, strengthen supply chain resilience, and advance technologies critical to national security. Peraso Inc. (NASDAQ: PRSO), whose fixed wireless access (FWA) solutions rely on cutting-edge semiconductors, stands to benefit significantly from this federal initiative.
Synergy CHC Corp. (NASDAQ: SNYR) is a consumer healthcare and beauty company established in 2010, focuses on marketing and distributing a diverse portfolio of health, wellness, and lifestyle brands across the United States, Canada, and the United Kingdom. The company is anchored by a portfolio of dynamic consumer health and lifestyle brands designed for today's wellness-conscious market:
Synergy CHC Corp. (NASDAQ: SNYR), a leading provider of consumer health and lifestyle products, today announced the appointment of Erik Shields as Vice President of Beverage, effective May 26, 2025. The strategic hire comes as the company accelerates its entry into the fast-growing functional beverage market with the expansion of its flagship brain health brand, FOCUSfactor .
Synergy CHC Corp. (NASDAQ: SNYR) is a consumer healthcare and beauty company established in 2010, focuses on marketing and distributing a diverse portfolio of health, wellness, and lifestyle brands across the United States, Canada, and the United Kingdom. The company is anchored by a portfolio of dynamic consumer health and lifestyle brands designed for today’s wellness-conscious market:
As market volatility continues to drive investor demand for high-upside plays, a new wave of stocks trading under $10 is capturing attention across multiple sectors—from consumer health and crypto-gaming to SaaS logistics and quantum tech. Companies like Synergy CHC Corp. (NASDAQ: SNYR), SharpLink Gaming Inc. (NASDAQ: SBET) , E2open Holdings (NYSE: ETWO) , and MicroCloud Hologram Inc. (NASDAQ: HOLO) are not only trading at attractive valuations but also showing signs of strategic inflection points that could unlock significant long-term value.
The Broadband Equity, Access, and Deployment (BEAD) Act, a $42.45 billion initiative by the U.S. government, is poised to revolutionize broadband access across rural and underserved regions. For Peraso Inc. (NASDAQ: PRSO) , a leader in fixed wireless access (FWA) technology, this legislation provides a significant opportunity to expand its market reach while addressing a critical global challenge: equitable connectivity.
Synergy CHC Corp. (NASDAQ: SNYR) is rapidly emerging as one of the most compelling small-cap opportunities in the booming consumer health sector. With shares trading around $1.96, Roth Capital has issued a Buy rating and a $10 price target , pointing to significant upside backed by strong fundamentals.
A wave of high-impact announcements is fueling explosive momentum across tech and healthcare stocks. From AI infrastructure to biotech M&A and consumer health expansion, investors are turning to breakout companies under $10 poised for rapid upside.
Synergy CHC Corp. (NASDAQ: SNYR), a leading provider of consumer health care and lifestyle products, has reported strong financial results for the first quarter ended March 31, 2025, marking its ninth consecutive quarter of profitability and signaling solid momentum for investors.
Synergy CHC Corp. (NASDAQ: SNYR), a consumer health and wellness brand powerhouse, reported 30% year-over-year EPS growth and its ninth straight profitable quarter . EBITDA margin jumped to 24.1%, fueled by cost discipline and strong brand traction for FOCUSfactor and Flat Tummy .
NEW YORK CITY, NEW YORK / ACCESS Newswire / April 17, 2025 / Synergy CHC Corp. (NASDAQ:SNYR), a leading consumer health and wellness company, proudly announces its participation in a six-part featured series on the acclaimed business television program "New to The Street", airing as sponsored programming on FOX Business and Bloomberg Television.
Invizyne Technologies opened on Nov. 13 at $11.10. Shares gained as much as 13% following the company's $15 million initial public offering. Additionally, Alpha Cognition opened on Nov. 12 at $7.00.
Ingram Micro and its private equity owner, Platinum Equity, sold 18.6 million shares at $22 each as the technology distributor returned to public trading in a busy week for the IPO market.
